(Q36679714)

15 August 2017

1 reference

title

Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer (English)

1 reference

15 August 2017

R Sankaranarayanan

1

1 reference

15 August 2017

publication date

1 November 2006

1 reference

International Journal of Gynecology and Obstetrics

15 August 2017

published in

1 reference

15 August 2017

volume

95 Suppl 1

1 reference

15 August 2017

page(s)

S205-10

1 reference

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Cancer survival in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Population-based survival for cervical cancer in Singapore, 1968-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

A critical assessment of screening methods for cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Screening for cervical neoplasia in an unselected rural Guatemalan population using direct visual inspection after acetic acid application: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Initial results from a randomized trial of cervical visual screening in rural south India

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Visual inspection as a cervical cancer screening method in a primary health care setting in Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

Cost-effectiveness of cervical-cancer screening in five developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2806%2960035-0

10.1016/S0020-7292(06)60035-0

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference